Showing 8 of 8 results

Marc Poncin et al.
Objective To describe the implementation and feasibility of an innovative mass vaccination strategy – based on single-dose oral cholera vaccine – to curb a cholera epidemic in a large urban...
Annick Lenglet, Vanessa Cramond, Penelope O’Connor, Hikmet Ahmed, Rosamund Southgate, Alan de Lima Pereira
Introduction: In 2015, following an influx of population into Kobanê in northern Syria, Médecins Sans Frontières (MSF) in collaboration with the Kobanê Health Administration (KHA) initiated...
MSF
Performance evaluation of MSF efforts, including immunization
Doctors Without Borders / MSF-USA
Diarrhea is still one of the main killers in developing countries. Rotavirus is the main agent that causes severe gastroenteritis. It can very quickly lead to fatal dehydration, especially among very...
James Smith
On Oct 10, 2015, Médecins Sans Frontières (MSF) rejected Pfizer\'s proposed donation of 1 million doses of its branded pneumococcal conjugate vaccine (PCV).1 The news caused a stir in the global...
VillageReach
At the end of 2015, the provincial government of Tete - with support from VillageReach and Médecins Sans Frontières (MSF) - contracted with a local third-party logistics provider to test a new...
Wright, V et al.
Many health care workers lack access to clinical support tools in rural and resource-limited settings. To address this gap, the Médecins Sans Frontières (MSF) Clinical Guidelines manual was...
Jayasree K. Iyer et al. MSF
The world’s largest pharmaceutical companies are developing promising new vaccines to tackle some of the world’s highest-burden diseases. This pipeline includes a group of first-ever vaccines,...